CPRX FY 2018 Earnings — Catalyst Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

CPRXCatalyst Pharmaceuticals, Inc.

$3B

FY 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$500,000

Gross Profit

-$19M-3883.8% margin

Operating Income

-$35M-7059.0% margin

Net Income

-$34M-6800.7% margin

EPS (Diluted)

$-0.33

Cash Flow

Operating Cash Flow

-$26M

Free Cash Flow

-$26M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$60M

Total Liabilities

$10M

Stockholders' Equity

$51M

Cash & Equivalents

$17M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$500,000	$0	—
Gross Profit	-$19M	-$45,689	-42403.0%
Operating Income	-$35M	-$19M	-88.9%
Net Income	-$34M	-$18M	-84.7%